UNC biochemist and age researcher Jonathan Schisler is part of the Coronavirus International Research Team, an interdisciplinary research working group formed by NASA to analyze COVID-19 data to address different aspects of the virus.
UNC researchers Ross Boyce and Allison Aiello are leading a study to understand how widespread cases of COVID-19 with mild or no symptoms are in the state and to monitor the prevalence of the disease over time.
The Coastal Resilience Center of Excellence has a new partnership with the country’s largest group of planning professionals, the American Planning Association. The group will use a planning scorecard from CRC that helps communities take steps to protect themselves from … Continued
Unlike COVID-19, eating disorders thrive in isolation, according to UNC researcher Cynthia Bulik. With an estimated 30 million Americans living with some type of eating disorder, nationwide stay-at-home orders challenge the health and recovery of many.
Rachel Despard is a senior majoring in music with minors in public policy and social and economic justice within the UNC College of Arts & Sciences. She studies how recorded music boosts community collaboration, affects visibility for vulnerable populations, and … Continued
Benjamin Mason Meier is analyzing policies across the globe that are being implemented to halt the spread of COVID-19. He wants to understand what powers governments have to prevent the disease and what policies are working in the disease response.
The UNC-based N.C. Policy Collaboratory will receive $29 million to study treatment, community testing, and prevention of COVID-19 under a $1.5 billion coronavirus relief package approved by state legislators and signed by Governor Roy Cooper.
FastTraCS is a small group of biomedical engineers who support UNC Health physicians, nurses, and staff by identifying problems in clinical settings and creating innovative, technological solutions. Here’s how team member Devin Hubbard is responding during COVID-19.
UNC psychiatry professor Karen Bluth is helping teens address their anxiety and stress during the pandemic by teaching online, four-week self-compassion classes.
Remdesivir, a drug developed by Gilead Sciences and tested at the UNC Gillings School of Global Public Health, proves effective against COVID-19 in NIAID human clinical trials.